Compound Detail
CHEMBL4079913
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)=CCC/C(C)=C/Cc1cc(O)cc2c1OC(/C=C(\C)CCC=C(C)C)C1=C2C(=O)C2=C(C1=O)S(=O)(=O)CCN2
Basic Information
| ChEMBL ID | CHEMBL4079913 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QDJNMAHTJHYJNV-FQLUOEGPSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
591.8
MW (Da)
6.22
ALogP
7
HBA
2
HBD
109.8
PSA (Ų)
0.26
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.13
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.13 | 6.12 | 740.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 740.0 | nM | 6.13 | Inhibition of Trypanosoma brucei recombinant farnesyltransferase using dansyl pe... | 28666857 |
| Unchecked | IC50 | = | 780.0 | nM | 6.11 | Inhibition of recombinant human farnesyltransferase using dansyl-GCVLS as substr... | 28666857 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28666857 | 10.1016/j.bmc.2017.06.029 | Unchecked | 2 |
| 28666857 | 10.1016/j.bmc.2017.06.029 | Plasmodium falciparum | 1 |
| 28666857 | 10.1016/j.bmc.2017.06.029 | L6 | 1 |
| 28666857 | 10.1016/j.bmc.2017.06.029 | Staphylococcus aureus | 1 |
| 28666857 | 10.1016/j.bmc.2017.06.029 | Staphylococcus intermedius | 1 |
| 28666857 | 10.1016/j.bmc.2017.06.029 | Pseudomonas aeruginosa | 1 |
| 28666857 | 10.1016/j.bmc.2017.06.029 | Escherichia coli | 1 |
Data from ChEMBL 36 via Core Engine